← All diseases

Inborn errors of metabolism

Zellweger spectrum disorder (ZSD)

An inherited disease of a structure inside the cells. Tiny sacs called peroxisomes do not form properly. The brain, liver, sight and hearing can be affected.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Inborn errors of metabolism” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Peroxisomes are tiny sacs inside the cell that break down certain fats and harmful substances. In this disease, peroxisomes do not form at all or work poorly. Very long-chain fats build up. The brain, liver, kidneys, eyes and ears can be affected. There are severe, intermediate and mild forms.

Which symptoms can occur?

Symptoms vary greatly from person to person. In the severe form they begin at birth; in the mild form they begin later.

  • Floppy muscles and feeding difficulties
  • Seizures (fits)
  • Hearing loss and vision problems
  • Liver problems and jaundice
  • Developmental delay
  • Distinctive facial features (in the severe form)
  • Tooth enamel problems and thinning of the bones (sometimes)

How is it diagnosed?

The first step is to measure very long-chain fats in the blood. Other peroxisome tests are also done on blood and urine. The diagnosis is confirmed with a genetic test.

Treatment and care

Care focuses on the symptoms and is the work of a team. Hearing aids, glasses and cataract surgery can help. A feeding tube into the stomach may be needed. Supplements of fat-soluble vitamins may be used. In the USA, there is an approved bile acid treatment for peroxisome disorders. The adrenal glands, bones and teeth are checked regularly. Early special education and physiotherapy are important. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. If the gene change is known, diagnosis during pregnancy is possible. Genetic counselling is recommended for the family.

Source: MedlinePlus Genetics: Zellweger spectrum disorder · NORD: Zellweger Spectrum Disorders · Orphanet: Peroxisome biogenesis disorder-Zellweger spectrum (ORPHA:79189)

Key facts

How is it inherited?
Autosomal recessive
When does it usually start?
Infancy, Newborn period

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Zellweger

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Inborn errors of metabolism: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:79189 · ICD-11 5C57.0

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.